ArticleClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2026
Use of Long-acting Injectable Antipsychotic Drugs in the Elderly: A Retrospective Study.
Article in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Despite the increasing use of long-acting injectable antipsychotics (LAIA) in the elderly population, there is still a lack of studies. This study aims to assess the treatment safety and tolerability of LAIAs in elderly patients. Methods: This retrospective study was conducted with patients over 60 years of age who were treated in the psychiatry clinic of a university hospital between 2014 and 2024 and underwent LAIA. Sociodemographic data, diagnoses, LAIA medications and side effects were obtained by accessing hospital records. Results: A total of 186 patients with a mean age of 70.20 (± 5.20) years were included in the study. The majority of patients were diagnosed with schizophrenia (53.2%), bipolar disorder (23.7%), and schizoaffective disorder (20.4%). The most commonly prescribed LAIA was paliperidone palmitate once-monthly 100 mg, with 19.9% of the patients. The most frequently used oral antipsychotic in combination with LAIA was olanzapine, used in 64 (34.2%) cases. No significant adverse effects related to the use of long-acting injectable drugs were observed. Conclusion: The utilisation of LAIAs in elderly patients appears to be both tolerable and safe. It can be considered for elderly patients suffering from chronic mental illness who are non-compliant with treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.